Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:09 AM
Ignite Modification Date:
2025-12-25 @ 3:09 AM
NCT ID:
NCT00226005
Eligibility Criteria:
Inclusion Criteria:
* Age \> 18
* Zubrod performance status of 0 - 2
* Histological or cytological diagnosis of pancreatic adenocarcinoma
* Measurable or evaluable disease determined as per RECIST criteria
* Life expectancy \> 12 weeks
* Written informed consent
* Patients must have failed or progressed on prior gemcitabine-based therapy for advanced or metastatic disease.
Exclusion Criteria:
* Islet cell or neuroendocrine carcinomas of the pancreas.
* History or presence of central nervous system disease.
* Patients with a history of another primary malignancy \< 5 years
* Prior chemo therapy \< 21 days prior to registration.
* Prior biologic or immunotherapy \< 14 days prior to registration
* Prior full field radiotherapy \< 28 days or limited field radiotherapy \< 14 days prior to registration.
* Major surgery \< 28 days prior to registration.
* Patients who have received investigational drugs \< 28 days prior to registration.
* Prior therapy with anti-VEGF agents.
* Pleural effusion or ascites that causes respiratory compromise.
* Female patients who are pregnant or breast feeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00226005
Study Brief:
Protocol Section:
NCT00226005